Well at least today we have started green. As a holder it is good to see your more positive dialogue on Cu6. Hopefully we have established a floor and some positive trial announcement is close for the price to bounce up.
Bell Potter's buy recommendation may not have generated much response or been given weight as they were involved in the IPO.
Anyway I am a long term holder who believes the Cu64/67 story. With some positive trial data and if favourable cost structure can be obtained this combination can replace Ga68/Lu77 in the treatment of Neuroendocrine tumours at least. Prostate and breast imaging and treatment of advanced disease are a lot more competitive and therefore of higher risk.
It would be good to have some feedback from some of our holders who have radionuclear expertise on their thoughts!
Regards
ASX: CU6 Outlook., page-14
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.01 |
Change
0.440(7.90%) |
Mkt cap ! $1.897B | |||
| Open | High | Low | Value | Volume |
| $5.68 | $6.17 | $5.68 | $9.760M | 1.629M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 3290 | $6.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.02 | 2458 | 11 |
View Market Depth
| Last trade - 14.40pm 12/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |